Patient-specific compartmental models for [177Lu]LuPSMA-617 therapy

被引：0
|
作者：
Li, W. [1 ]
Kupitz, D. [2 ,3 ]
Spielmann, V. [1 ]
Kamp, A. [1 ]
Katzdobler, L. [1 ]
Giussani, A. [1 ]
Kreissl, M. [2 ,3 ,4 ]
Grosser, O. [2 ,3 ,4 ]
机构：
[1] Bundesamt Strahlenschutz, Oberschleissheim, Germany
[2] Otto von Guericke Univ, Univ Hosp Magdeburg, Dept Radiol & Nucl Med, Magdeburg, Germany
[3] Otto von Guericke Univ, Fac Med, Magdeburg, Germany
[4] Otto von Guericke Univ, Res Campus STIMULATE, Magdeburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0920
引用
收藏
页码：S799 / S800
页数：2
相关论文
共 50 条
  • [31] Radiochemical aspects of synthesis and analysis of [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T single-dose preparations
    Larenkov, Anton
    Rakhimov, Marat
    Pavlenko, Ekaterina
    Kodina, Galina
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S152 - S152
  • [32] Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC
    Wehrmann, Christiane
    Senftleben, Stefan
    Zachert, Carolin
    Mueller, Dirk
    Baum, Richard P.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (03) : 406 - 416
  • [33] Predicting benefit from [177Lu]Lu-PSMA-617 therapy: what do we need to know?
    Sartor, Oliver
    LANCET ONCOLOGY, 2022, 23 (11): : 1344 - 1345
  • [34] Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
    Florian Rosar
    Niklas Schön
    Hendrik Bohnenberger
    Mark Bartholomä
    Tobias Stemler
    Stephan Maus
    Fadi Khreish
    Samer Ezziddin
    Andrea Schaefer-Schuler
    EJNMMI Physics, 8
  • [35] Production logistics of 177Lu for radionuclide therapy
    Pillai, MRA
    Chakraborty, S
    Das, T
    Venkatesh, M
    Ramamoorthy, N
    APPLIED RADIATION AND ISOTOPES, 2003, 59 (2-3) : 109 - 118
  • [36] Comparison of Voxel S-values and Monte Carlo Simulation in [177Lu]Lu-DOTA-TATE Quantification for Patient-Specific Dosimetry
    Rodrigues, C.
    Ferreira, P.
    Oliveira, F. P. M.
    Silva, A.
    Peralta, L.
    Costa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S75 - S75
  • [37] Molecular imaging and biochemical response assessment after a single cycle of [225Ac]Ac-PSMA-617/[177Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [177Lu]Lu-PSMA-617 monotherapy
    Rosar, Florian
    Hau, Fabian
    Bartholoma, Mark
    Maus, Stephan
    Stemler, Tobias
    Linxweiler, Johannes
    Ezziddin, Samer
    Khreish, Fadi
    THERANOSTICS, 2021, 11 (09): : 4050 - 4060
  • [38] BEST PRACTICES IN THE ADMINISTRATION OF [177LU]LU-PSMA-617 RADIOLIGAND THERAPY FOR PROSTATE CANCER IN US CENTERS
    Spitz, Avery
    Gardner, Linda
    Floyd, Rebecca
    Sutton, Jennifer
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [39] The role of kidneys and bone marrow as critical organs during Lu-177-PSMA-DKFZ-617 therapy depending on the patient-specific tumor load
    Gosewisch, Astrid
    Ilhan, Harun
    Todica, Andrei
    Brosch, Julia
    Kaiser, Lena
    Bartenstein, Peter
    Boening, Guido
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [40] Automatic bone marrow segmentation for precise [177Lu]Lu-PSMA-617 dosimetry
    Lu, Zhonglin
    Hu, Jiaxi
    Chen, Gefei
    Jiang, Han
    Shih, Cheng-Ting
    Afshar-Oromieh, Ali
    Rominger, Axel
    Shi, Kuangyu
    Mok, Greta S. P.
    MEDICAL PHYSICS, 2025,
12345